Platelet-activating factor (PAF) stimulates human B cells, resulting in elevation of intracellular calcium and the release of inositol phosphates. This signaling pathway is inhibited in the presence of pertussis (PT) or cholera toxin (CIT). Preincubation of human B cells with either toxin, but not their inactive subunits, for 3 h blocked these PAF-induced responses in two B-lymphoblastoid cell lines. This effect was time dependent, with some inhibition noted at 30 min, but only after preincubation for 2-3 h was maximum inhibition achieved. This inhibitory activity was also dose dependent. The toxins blocked both PAF-induced transmembrane uptake of Ca2" as well as release of Ca2" from internal stores, and were selective in that activation events after cross-linking of surface IgM were not affected. Further, the toxins did not appear to act through elevation of intracellular levels of cAMP. These data, coupled with previous observations on the absence of heterologous desensitization between PAF and sIgM receptors, may delineate distinct signaling pathways in human B cells. This may reflect different roles for GTP-binding proteins in the activation of human B cells. (J. Clin. Invest. 1992. 90:759-765.)
Introduction
Platelet-activating factor (PAF)' is an ether-linked phospholipid that can modulate vascular, muscular, and immune function. It is commonly thought to act via a specific receptor, although to date this has been inferred from indirect measures such as radiolabeled PAF binding or by the inhibitory effects of specific receptor antagonists ( 1 ) . There also appears to be multiple signaling pathways that are activated after the interaction of PAF with its specific receptor.
Cell activation after PAF binding has been demonstrated to be mediated via activation ofa GTP-binding protein in human and rabbit polymorphonuclear leukocytes (2, 3) and rabbit and human platelets (4, 5) . The specificity ofthese G proteins, as defined by pertussis (PT) and cholera (CT) toxin sensitivity, differs between PMNs and platelets (5) . PAF-induced hydrolysis of GTP (GTPase activity) in human neutrophils is completely inhibited by PT and CT, while the same biochemical reaction in human platelets is insensitive to PT and CT (5) . This unique profile has led Hwang ( 1, 5) to postulate the existence of at least two different classes of PAF receptors in human cells, each triggering a specific pathway for signaling.
Recently we reported that interaction ofPAF with its receptor causes an increase in intracellular levels of calcium, liberation of inositol phosphates, and expression of early oncogenes in a number of B-lymphoblastoid cell lines (6) . These actions are completely blocked by PAF receptor antagonists (6) . PAF appears to be a unique ligand for these lymphocytes since it triggers a very rapid Ca2+ response when compared to the response of sIgM cross-linking (6) . Further, PAF is not responsible for heterologous desensitization of the response to crosslinking surface IgM receptors (6) . A potential explanation for the difference in signaling pathways between the PAF and sIgM receptors in B lymphocytes is suggested by their respective sensitivity to PT and CT. Although some B-lymphoblastoid cell lines will mobilize Ca2+ and hydrolyze phosphatidylinositol bisphosphate (PIP2) when stimulated by anti-IgM antibody (7, 8) , anti-IgM-mediated PIP2 hydrolysis cannot be blocked by PT or CT (9) .
In view of the potential differences between PAF-and antiIgM-mediated cell activation, we have attempted to define the signaling pathway that PAF initiates upon interaction with its specific receptor. The data suggest that the increase in intracellular Ca2+ levels elicited by PAF is via a PT-and CT-sensitive pathway that is not influenced by elevated cAMP levels. The data confirm that PAF-induced hydrolysis of PIP2 and generation of inositol phosphates is regulated through the same pathway. This pattern is similar to human polymorphonuclear leukocytes (5) . We also demonstrate that the signaling pathway for anti-IgM is different from that of PAF in that it is sensitive neither to the toxins nor to elevated cAMP. This may explain the lack of heterologous desensitization between these two ligands.
Methods
Cell lines. The B-lymphoblastoid cell lines used in this series of experiments included the HSCE-cell line, an IgG-secreting EBV-transformed B-cell line, and LA350, an sIgM-secreting and IgM-expressing lines were maintained in culture in RPMI 1640 (Gibco Laboratories, Grand Island, NY) supplemented with 10% FCS (HyClone Laboratories, Logan, UT) and 50 U/ml penicillin, 50 ng/ml streptomycin, 10 ,g/ml L-glutamine, and 5 Mg/ml sodium pyruvate, all purchased from Gibco Laboratories. Passages were performed biweekly and new cultures were established from frozen stock approximately every 8 wk.
Ligands. Platelet activating factor (C-16), enantio-PAF, and lyso-PAF were purchased from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA). These were reconstituted in ethanol and stored at -20°C until use. Aliquots of PAF or its analogues were freshly prepared for each experiment by drying down the lipid under a stream of nitrogen and resuspension in PBS containing 0.125% BSA by sonification. Pertussis and cholera toxins were purchased from Calbiochem Corp. (San Diego, CA). The B-oligomer of pertussis toxin and the B-subunit of cholera toxin were also obtained from Calbiochem Corp. These compounds were reconstituted with distilled water according to the manufacturers' instructions, and stored at 4°C until use. Forskolin was purchased from Calbiochem Corp. and 8-bromo cAMP and theophylline were purchased from Sigma Chemical Co. (St. Louis, MO).
Anti-IgM ((Fab'12) was purchased from Tago, Inc. (Burlingame, CA).
Medium. Serum-free medium with supplemental transferrin was prepared as described previously ( 10) . We have demonstrated that cell viability and immunoglobulin synthesis were equivalent in this medium compared to FCS-containing medium; however, the serum-free medium contains no acetylhydrolase activity, allowing for optimal activity and control of PAF in vitro (10 ( 11 ) . Analysis ofinositolphosphate liberation. Cells were washed twice in PBS and suspended (5 X 106/ml) in DME supplemented with 100 U/ml penicillin, 100 ug/ml streptomycin, 2 mM L-glutamine, 100 ,gg/ml sodium pyruvate, and 0.25% BSA to which was added 1 MCi/ml [3H]myoinositol (12) . After 20-22 h of incubation at 37°C, the cells were washed twice in the medium and incubated with 20 ,gM LiCl for 15 min. Cells were then centrifuged and resuspended in medium with 20 MM LiCl. Aliquots (500 Ml) of the cell suspension were then incubated with PAF ( l0 -M) or the suspension vehicle at 37°C. At varying times 1.5 ml CHC13:CH30H ( 1:2) were added to stop the reaction. The lipids were extracted by addition of 0.5 ml chloroform and 0.5 ml dH2O. The upper aqueous phase was collected, pH adjusted to 7.2, and stored at 4°C until use. The total aqueous phase was applied to 0.6 ml columns of Dowex AG1-X8 (200-400 mesh; Bio-Rad Laboratories, Richmond, CA) in the formate form. The columns were washed with 20 ml of water to remove inositol and neutralize HCI. Glycero-phosphoinositol was eluted with 20 ml of 2. such as lyso-PAF (6) and enantio-PAF (Fig. 1 , B and C) do not cause an elevation of [Ca2+]i, and the action is blocked by specific PAF antagonists (6) . To examine if inhibition of PAFinduced signaling could be achieved with PT or CT, the cell lines HSCE-or LA350 were incubated for 3 h with 100 ng/ml of either PT or CT. A marked inhibition of the calcium response was observed after addition of l0-7 M PAF to PT-or CT-treated B-lymphoblastoid cells, compared to control (Fig.  1) . The inhibition at the dose of 100 ng/ml appeared to be equally effective in blocking both the transient peak of the biphasic calcium curve and the plateau response. At concentrations of 100 ng/ml, neither the B-oligomer ofPT nor the B-subunit of CT affected the Ca2" response in LA350 cells triggered by PAF (Fig. 1) . has not been influenced by CT in either human ( 14) or murine B-cell lines ( 15 ) . Indeed, we found that after a 3-h incubation with PT or CT and anti-IgM stimulation of the LA350 line (Fig. ) , there was no variation in the Ca2" response compared to control. Similarly the B-subunits of the toxins were inactive (data not shown). The PAF response was markedly diminished under the same conditions.
The inhibitory effect of the toxins on the PAF-induced increases in [Ca2 ]i was dose dependent. After a 3-h incubation with various concentrations of PT or CT, the IC50 of PT was 8±5 ng/ml (Fig. 2 , A and C) while the IC50 for CT was found to be 40±8 ng/ml (Fig. 2, B and D) . To define further the effect of the toxins on the individual components of the calcium response, approximate IC50 doses of PT (5 ng/ml) and CT (50 ng/ml) were used in order to avoid the > 90% inhibition achieved with higher concentrations of the toxins. Experiments were performed using indo-lloaded B-lymphoblastoid cells suspended in Ca2"-free medium. The cells were stimulated with PAF, which caused a rapid but transient increase in [Ca" ]i (Fig. 3 A) . mM ofCa2" was then added, leading to an increase in [Ca2+]i and a more sustained plateau representing transmembrane uptake. After incubation with 5 ng/ml of PT (Fig. 3 B) or 50 ng/ml of CT (Fig. 3 C) , both the transient peak and the plateau phase responses were blunted. This implies that blocking of GTP-binding protein activation by the toxins influences both the liberation of Ca" from internal stores, and transmembrane Ca" uptake, presumably through ligand-gated calcium channels. At these lower concentrations of the toxins, a more prominent action on Ca" uptake than release from internal stores was (17). PAF has been suggested to be a potent activator ofPLC in many cell systems ( 18, 19) including B lymphocytes (6), inasmuch as PIP2 breakdown products IP3, IP2, and IP, accumulate rapidly after PAF stimulation ofcells. After the incubation of HSCE- (Fig. 4 ) or LA350 cells (data not shown) with PT or CT, PAF stimulation generated a minimal liberation of inositol phosphates. Again, PT and CT did not stimulate IP liberation on their own (data not shown). Inhibition ofthe PAF response is not due to elevated cAMP. It is well documented that after binding ofCT to the a,, subunit ofG-protein complexes, intracellular cAMP levels are elevated (20) . In some B-cell systems, increased levels of cAMP have been demonstrated to diminish cellular responsiveness to ligand-induced elevations of [Ca2+]i after anti-Ig stimulation (21, 22) . HSCE-cells (Fig. 5 ) and LA350 cells (Fig. 6) were preincubated for 30 min with various doses of forskolin ( I0--l0-' M) or the cAMP analogue 8-bromo-cAMP (l0-4 M) alone or in combination with 100 ,uM theophylline. Under these conditions the protein kinase A activity ratio (23) increased from four-to sixfold with 8-bromo-cAMP and forskolin, respectively, when compared to controls, and these increases were sustained over the course of the experiment. Neither of these treatments had an effect on the PAF-indu'ced increases in [Ca2+]i (Fig. 5) or on the Ca2' response induced by anti-IgM (Fig. 6) . In additional studies (data not shown), method of signal transduction is important for development of pharmacologic agents to counteract its effects. We have previously reported that PAF stimulates B lymphoblasts, leading to elevations of [Ca2 ]i and liberation of inositol phosphates (6) .
However, definition of the precise signaling pathway through the PAF receptor has not been easy to accomplish in different cell types and interspecies variability has been observed (1 (25) . Human neutrophils, in contrast, are sensitive to both PT and CT ( 1, 5), as no PAFstimulated GTPase activity was found following incubation with the toxins (5).
The ability of PAF to cause biochemical changes after receptor ligand interaction in B lymphocytes provides an opportunity for comparative studies of signal transduction pathways in these cells. This is due to the availability of specific antagonists to PAF, and, more importantly, because of the ability to contrast with signaling through the sIgM receptor (6) . We therefore undertook to delineate the sensitivity of the PAF receptor to preincubation with PT and CT, both of which have been demonstrated to inhibit PAF-mediated signaling in human hematopoietic cells and modulate the function of GTP binding proteins. These studies were performed with the IgG- (6, 26) .
The PAF receptor on B-lymphoblastoid cell lines appears to be similar to human polymorphonuclear leukocytes, that is, sensitive to both PT and CT (5) . The elevation of intracellular Ca21 levels triggered by the addition of PAF in the two B-lymphoblastoid cell lines was inhibited after a 3-h preincubation of the cells with either PT or CT. This inhibition was both timeand dose-dependent as well as specific, as it did not alter Ca21 mobilization induced by anti-IgM stimulation of LA350 cells (Fig. 1) . Further, the inactive B-subunits of both CT and PT did not affect the Ca2' response induced by PAF ( 16, 27, 28 ).
Monitoring cells suspended in Ca2"-free medium revealed that the toxins inhibited both phases of the Ca2' response, the initial transient peak due to the release ofinternal Ca2+ stores, and the plateau phase, primarily representing transmembrane uptake of Ca2+. In the presence of lower concentrations of the toxins, some dissociation of their effects could be observed, suggesting that transmembrane uptake of Ca2l was the more sensitive component of the response. Since release of Ca2l from internal stores may be mediated by the release of IP3 from membrane phospholipids (29), we examined whether IP metabolism was inhibited by PT and CT as well. We showed that 100 ng/ml PT and CT markedly attenuated the hydrolysis of PIP2 to IP1, IP2, and IP3.
PT and CT both bind to a subunits of GTP-binding proteins (30) . CT ADP-ribosylates as residues causing a marked increase in intracellular levels of cAMP. PT is known to ADPribosylate ai and a. in GTP-binding proteins and transducins (31 ) . As a result, PT inhibits adenylate cyclase, with an opposite effect on cAMP compared to CT. PT modifies the GTPbinding subunits by binding to a cystine residue that is highly conserved in the Gj/. and transducin subtypes. In contrast, the CT ADP-ribose acceptor site is an arginine residue found not only in as subunits, but also in ai, a., and transducins. Therefore, known PT-sensitive G-protein subunits or cytoskeletal elements have been demonstrated to be ADP-ribosylated by CT, such as in retinal rod membranes (32) , neuroblastoma cell lines (31) , and HL-60 cells (33). The effects of CT in these cases are independent ofcAMP, and are distinctly like PT-mediated events. This mechanism has been suggested by Imboden et al. (27) , who demonstrated that CT inhibited both eleva- In comparing the elevations in [Ca2+]i by PAF and antiIgM in cell lines with both receptors, we observed that there was no heterologous desensitization between these two ligands (6). The phenomenon ofhomologous or heterologous desensitization was first described in the #-adrenergic system (35) .
Desensitization, although not well understood, is likely due to the uncoupling of receptors secondary to distal biochemical events such as the elevation ofcAMP and protein phosphorylation after receptor-ligand interaction. In B-lymphocyte cell lines, Ca2+ signaling through sIgM can be desensitized after stimulation with anti-IgD (36), anti-CD19 (36), and anti-CD21 (37 There have been attempts to link anti-IgM signaling to GTP-binding proteins, but these have been limited by the inability to block early signal transduction events with either PT or CT. Anastassiou et al. (14) showed that while CT could block B-cell proliferation induced by anti-IgM antibodies, there was no effect of CT (or forskolin) on anti-IgM-induced elevation of [Ca2+ ]j. Harnett The inability of these responses to be inhibited by PT or CT forced the authors to conclude that GTP-binding proteins coupled to the sIgM receptor are of an unidentified type. There is also evidence that signaling via sIgM may be through PLC-,y1. This was demonstrated by Carter et al. (38) (39) and from human peripheral leukocytes (40) . Their analysis of the gene for the receptor shows homology with other members of the G-protein-coupled receptor family, supporting this hypothesis.
In summary, we have demonstrated that PAF-induced increases in intracellular Ca2+ and PIP2 hydrolysis are sensitive to both pertussis and cholera toxins. Therefore, the PAF receptor found in human B-lymphoblastoid cell lines is most likely coupled to its receptor via a GTP-binding protein. It appears that this receptor has characteristics similar to those expressed by human polymorphonuclear leukocytes, and indicates that the PAF receptor on human B cells may also belong to the GTPbinding protein superfamily.
